Kelly Polinski and Amy Suss Featured in Employee Benefit News for Co-Authored Article

Benefits Think: How to best mitigate the cost of cancer treatments

By Kelly Polinski, Senior Director, Population Health & Well-Being and Amy Suss, PharmD, Senior Clinical Manager National Pharmacy Team

Nearly half of employers that track condition-specific data cite cancer as the No. 1 contributor to higher healthcare expenses, according to the 2025 Brown & Brown Employer Health and Benefits Strategy Survey.

Advancements in the precision and effectiveness of cancer treatments and medications come at a higher price point. While these improvements hold clinical promise, they are also driving up costs.

Read more from Kelly and Amy on the Employee Benefit News website.

Note that the article may be behind a paywall.